MoneyWorks4Me

Aarey Drugs & Pharma - Quaterly Results

08 Feb 2023 Evaluate
The sales moved down -55.46% to Rs. 624.71 millions for the December 2022 quarter as compared to Rs. 1402.67 millions during the corresponding quarter last year.The Company to register a -74.63%  fall in the net profit for the quarter ended December 2022.Operating profit for the quarter ended December 2022 decreased to 20.06 millions as compared to 31.87 millions of corresponding quarter ended December 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 624.71 1402.67 -55.46 2560.73 3724.34 -31.24 4926.80 3484.16 41.41
Other Income 4.78 1.27 276.38 18.91 16.13 17.23 27.48 70.15 -60.83
PBIDT 20.06 31.87 -37.06 70.92 110.19 -35.64 140.15 116.53 20.27
Interest 7.10 4.90 44.90 18.49 15.70 17.77 20.00 24.32 -17.76
PBDT 12.96 26.97 -51.95 52.43 94.49 -44.51 120.15 92.21 30.30
Depreciation 5.51 5.00 10.20 13.74 14.00 -1.86 19.88 9.20 116.09
PBT 7.45 21.97 -66.09 38.69 80.49 -51.93 100.27 83.01 20.79
TAX 2.51 2.50 0.40 4.56 7.50 -39.20 34.82 17.87 94.85
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.08 1.23 -187.80
PAT 4.94 19.47 -74.63 34.13 72.99 -53.24 65.45 65.14 0.48
Equity 253.85 253.85 0.00 253.85 253.85 0.00 253.85 233.85 8.55
PBIDTM(%) 3.21 2.27 41.33 2.77 2.96 -6.39 2.84 3.34 -14.95
Peers